GlassScriptPhysician profile
Wesley K Ghasem
NPI 1083068936
$14,407.31
in general payments reported to CMS, 2019-2025
20 companies · $2,720 in 2025
The $2,720 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $127 · 2021: $521 · 2022: $561 · 2023: $8,871 · 2024: $1,371 · 2025: $2,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,000 · Food and Beverage: $4,797 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,000.00 |
| Food and Beverage | $4,796.81 |
| Education | $164.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,036.02 | 2023-2025 | Symplicity G3, Micra, Onyx Frontier |
| Boston Scientific Corporation | $1,225.32 | 2019-2024 | Avvigo Guidance System, Watchman Flx, Hornet 10 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $800.77 | 2021-2024 | Lifevest |
| Abiomed | $763.11 | 2024-2025 | Impella |
| Abbott Laboratories | $675.90 | 2024-2025 | Navitor, Triclip, Pressurewire |
| Shockwave Medical, INC | $602.21 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $349.19 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $188.38 | 2022-2025 | Farxiga |
| Penumbra, INC. | $145.73 | 2022 | |
| Edwards Lifesciences Corporation | $141.55 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $115.51 | 2022-2025 | |
| Lilly USA, LLC | $103.07 | 2023 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $66.69 | 2025 | Eliquis, Camzyos |
| Biosense Webster, INC. | $50.00 | 2024 | Carto 3 |
| Teleflex LLC | $34.46 | 2023 | Guideliner |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $32.63 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.99 | 2025 | Jardiance |
| Lantheus Medical Imaging, INC. | $21.87 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2025 | |
| Chiesi USA, INC. | $13.29 | 2023 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Ghasem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.